1.
Sachdev JC, Snider JN, Allen JW, Schwartzberg LS, Young RR, Javed AY, Smeltzer MP, Yunus F, Verrier CS, Jahanzeb M. NEOADJUVANT WEEKLY NAB-PACLITAXEL PLUS CARBOPLATIN FOLLOWED BY DOXORUBICIN PLUS CYCLOPHOSPHAMIDE WITH BEVACIZUMAB ADDED CONCURRENTLY TO CHEMOTHERAPY FOR OPERABLE TRIPLE-NEGATIVE INVASIVE BREAST CANCER. J Cancer Allied Spec [Internet]. 1 [cited 2024Mar.29];2(1). Available from: https://journals.sfu.ca/jcas/index.php/jcas/article/view/59